Dr. Marie-Laure Yaspo

Dr. Marie-Laure Yaspo is the Co-Founder and Chief Scientific Officer at Alacris Theranostics, a biotech firm in Berlin specializing in precision oncology with advanced molecular tumor diagnostics. She also leads the Otto Warburg Laboratory at the Max Planck Institute for Molecular Genetics. Dr. Yaspo has been instrumental in international projects like sequencing Human chromosome 21, the International Cancer Genome Consortium, and Treat20Plus, a study on metastatic melanoma with Charité Comprehensive Cancer Center. She earned her PhD in Paris and conducted postdoc research in London.